Stat Consult Slideshows
This slideshow reviews bevacizumab (Avastin), indicated for metastatic renal cell carcinoma with interferon alfa.
This slideshow reviews clonazepam (Klonopin), indicated for the treatment of panic disorder, with or without agoraphobia (as defined in DSM-IV), ...
This slideshow reviews doxorubicin (Adriamycin), indicated for the treatment of acute lymphoblastic leukemia, acute myeloblastic leukemia, Hodgkin lymphoma, and non-Hodgkin ...
This slideshow reviews olaparib (Lynparza), indicated as monotherapy in patients with deleterious or suspected deleterious germline BRCA mutated advanced ovarian ...
This slideshow reviews zoledronic acid (Zometa), indicated for pain reduction associated with bone metastases, hypercalcemia of malignancy, and osteolytic lesions ...
This slideshow reviews fluorouracil (5-FU), indicated for palliative treatment of breast cancer, colorectal cancer, gastric cancer, and carcinoma of the ...
This slideshow reviews netupitant/palonosetron (Akynzeo), indicated for prevention of acute and delayed nausea and vomiting associated with initial and repeat ...
This slideshow reviews bevacizumab (Avastin), indicated for cervical cancer, in combination with paclitaxel and cisplatin or paclitaxel and topotecan in ...
This slideshow reviews ramucirumab (Cyramza), indicated for advanced gastric or gastro-esophageal junction (GEJ) adenocarcinoma.
This slideshow reviews erlotinib (Tarceva), indicated for metastatic non-small cell lung cancer.
This slideshow examines cisplatin (Platinol), indicated for metastatic testicular tumors, metastatic ovarian tumors, and advanced bladder cancer.
This slideshow reviews arsenic trioxide (Trisenox), indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL).
This slideshow reviews trastuzumab (Herceptin), indicated for the treatment of HER2-overexpressing breast cancer, metastatic gastric cancer, or gastroesophageal junction adenocarcinoma.
This slideshow reviews oxaliplatin (Eloxatin), for the treatment of advanced colorectal cancer.
This slideshow reviews ipilimumab (Yervoy), for the treatment of unresectable or metastatic melanoma.
This slideshow reviews obinutuzumab (Gazyva), for the treatment of patients with previously untreated chronic lymphocytic leukemia (CLL), in combination with ...
This slideshow reviews methylnaltrexone (Relistor), for the treatment of constipation caused by narcotic medication for patients with advanced illness who ...
This slideshow examines imatinib (Gleevec), indicated for Philadelphia chromosome positive chronic myeloid leukemia and relapsed Philadelphia chromosome positive acute lymphoblastic ...
This slideshow reviews asparaginase erwinia chrysanthemi (Erwinaze), indicated for treatment acute lymphoblastic leukemia (ALL) in patients with a hypersensitivity to ...
This slideshow reviews gemcitabine (Gemzar), for the treatment of advanced ovarian cancer or for treatment for first-line treatment of metastatic ...
Stat Consult Articles
Zoledronic acid is a third-generation bisphosphonate prescribed to reduce pain from bony metastases, treat hypercalcemia of malignancy, and manage osteolytic lesions in multiple myeloma.
Doxorubicin is an anthracycline antibiotic that is used to treat lymphoblastic and acute myeloblastic leukemias, several types of cancer, Kaposi sarcoma related to AIDS, malignant lymphoma, soft tissue and osteogenic sarcomas, and Wilms tumor.
- Vitamin D and prostate cancer: Higher intake improves active surveillance outcomes
- Muscle-building supplements may be associated with testicular cancer
- Triple combination of two targeted therapies + immunotherapy is more effective in advanced melanoma
- Promising drug target identified in medulloblastoma
- Physical activity associated with less chemo-induced peripheral neuropathy
- mHealth app assesses breast cancer risk and aids prevention
- Socioeconomic factors increase mortality after lung cancer surgery
- Half of older U.S. adults take aspirin as preventive medicine
- Cardiorespiratory fitness linked with decreased metabolic syndrome risk among smokers
- Adjuvant chemotherapy in non-small cell lung cancer: State-of-the-art
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|